HomeIPCALAB • NSE
add
IPCA Laboratories Ltd
Previous close
₹1,312.20
Day range
₹1,311.00 - ₹1,334.50
Year range
₹1,168.20 - ₹1,755.90
Market cap
333.87B INR
Avg Volume
150.37K
P/E ratio
42.87
Dividend yield
0.30%
Primary exchange
NSE
Financials
Income Statement
Revenue
Net income
| (INR) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 23.09B | 10.33% |
Operating expense | 13.01B | 12.60% |
Net income | 2.33B | 21.31% |
Net profit margin | 10.10 | 9.90% |
Earnings per share | 9.19 | 21.24% |
EBITDA | 4.09B | 8.41% |
Effective tax rate | 29.21% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 11.05B | 29.36% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 83.88B | — |
Shares outstanding | 253.76M | — |
Price to book | 4.79 | — |
Return on assets | — | — |
Return on capital | 8.11% | — |
Cash Flow
Net change in cash
| (INR) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 2.33B | 21.31% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Ipca Laboratories Limited is an Indian multinational pharmaceutical company based in Mumbai. It produces theobromine, acetylthiophene, and p-bromotoluene as active pharmaceutical ingredients. Ipca sells these APIs and their intermediates globally. It produces more than 150 formulations that include oral liquids, tablets, dry powders, and capsules. Wikipedia
Founded
Oct 19, 1949
Website
Employees
16,778
